OR WAIT null SECS
January 02, 2021
The recently published European pharmaceutical strategy is being seen as an opportunity to strengthen medicines regulation in the region.
December 31, 2020
Administration of the COVID-19 vaccination from Oxford University and AstraZeneca is expected to begin in the UK in early 2021.
December 21, 2020
A decision by the European Commission on conditional marketing authorization for the European Union’s first COVID-19 vaccine is expected soon.
December 15, 2020
The HERALD trial will involve participants 18 years and older who will receive a two-dose schedule of CVnCoV or placebo at multiple sites is Europe and Latin America.
The company will expand its clinical supply chain services by establishing two new facilities in Rheinfelden and Weil am Rhein, Germany.
Trixeo Aerosphere—AstraZeneca’s triple-combination COPD therapy—has been approved for use in the European Union (EU).
Sterling Pharma Solutions has formed a new strategic partnership with ADC Bio.
A report, launched by Takeda UK, has shown that despite the increase in media attention, COVID-19 has had little positive impact on the perception of pharmaceutical companies.
December 11, 2020
ISPE and Gilead Sciences have partnered up for the establishment of an internship program.
The European Commission has granted a license for the use of inclisiran (Leqvio) as a treatment of primary hypercholesterolemia or mixed dyslipidaemia in adult patients.